Evidence map›Paper›PMID 31120933›Full record

Observational studyPloS one2019

An enhanced clot growth rate before in vitro fertilization decreases the probability of pregnancy.

A N Balandina, E M Koltsova, T A Teterina, A G Yakovenko, E U Simonenko, A V Poletaev, I V Zorina, A M Shibeko, T A Vuimo, S A Yakovenko and 1 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

A N BalandinaDmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
E M KoltsovaDmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.ORCID 0000-0003-0167-6726
T A TeterinaAltraVita IVF clinic, Moscow, Russia.
A G YakovenkoAltraVita IVF clinic, Moscow, Russia.
E U SimonenkoLomonosov Moscow State University, Moscow, Russia.
A V PoletaevDmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
I V ZorinaAltraVita IVF clinic, Moscow, Russia.
A M ShibekoDmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.ORCID 0000-0003-1494-3125
T A VuimoDmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
S A YakovenkoAltraVita IVF clinic, Moscow, Russia.
F I AtaullakhanovDmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
Center for Theoretical Problems of Physicochemical Pharmacology · RUNeuroVita Clinic · RULomonosov Moscow State University · RUDmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology · RUMoscow Institute of Physics and Technology · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe shift towards hypercoagulation during in vitro fertilization (IVF) can lead to the impairment of embryo implantation and placental blood circulation, which is believed to be a factor in an unsuccessful IVF cycle.

objectivesTo assess coagulation in women with infertility before the start of an IVF cycle and during treatment to reveal the association between coagulation imbalance and IVF outcome. PATIENTS/

methodsWe conducted a prospective cohort observational study including 125 participants who underwent fresh IVF cycles. Blood samples were collected at five time points: before IVF, one week after the start of controlled ovarian stimulation (COS), on the day of follicular puncture, on the day of embryo transfer (ET) and one week after ET. Coagulation tests (clotting times: activated partial thromboplastin time (APTT) and prothrombin; fibrinogen and D-dimer concentrations; thrombodynamics) were performed.

resultsWomen with an elevated clot growth velocity (>32.3 μm/min, detected by thrombodynamics) before IVF demonstrated a higher risk of negative IVF outcomes (adjusted RR = 1.38; 95% CI 1.28-1.49; P<0.001). During the procedure, we observed increases in prothrombin, fibrinogen and D-dimer concentrations, a slight shortening of APTT and a hypercoagulation shift in the thrombodynamics parameters. The hemostasis assay values during COS and after ET had no associations with IVF outcomes.

conclusionsHypercoagulation in the thrombodynamics before the start of IVF treatment was associated with negative IVF outcomes. After the start of COS, all tests demonstrated a hypercoagulation trend, but the hypercoagulation did not influence IVF outcome. This research is potentially beneficial for the application of thrombodynamics assay for monitoring hemostasis in infertile women prior to an IVF procedure with the goal of selecting a group requiring hemostasis correction to increase the chances of pregnancy.

Indexed as

Blood CoagulationFertilization in VitroAdultBlood Coagulation DisordersBlood Coagulation TestsCohort StudiesEmbryo TransferFemaleHumansInfertility, FemalePregnancyPregnancy RateProspective StudiesRisk Factors

Identifiers

PMID31120933
PMCPMC6532853
OpenAlexW2945709107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.